Menu

1 / 3

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials

Business - Latest - Google News·10 days ago
#kVU3kjcV
#world#news#medicalxpress#knee#pain
Reading 0:00
15s threshold

Credit: Unsplash/CC0 Public Domain

For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about one-quarter of their body weight on average.

A pooled analysis of the studies found that about two-thirds of participants receiving retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving placebo.

In addition to weight loss and pain relief, participants experienced other significant benefits, including reduced blood pressure, lower lipid levels and less systemic inflammation.

The findings from both trials have been published in the New England Journal of Medicine .…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.